TGFBR2 and neoplasm: Meanwhile, mutation of TGFBR2 (TGF-β receptor type II), a tumor suppressor gene, is less frequently detected in lesions in PanIN/PDAC compared with SMAD4/DPC47, both of which function in the TGF-β-SMAD signaling pathway.